-+ 0.00%
-+ 0.00%
-+ 0.00%

Eckert Wagniskapital und Frühphasenfinanzierung, closely associated with supervisory board member Andreas Eckert, buys Pentixapharm shares for EUR 7.34 million via subscription rights exercise

PUBT·08/17/2026 07:21:23
Listen to the news
Eckert Wagniskapital und Frühphasenfinanzierung, closely associated with supervisory board member Andreas Eckert, buys Pentixapharm shares for EUR 7.34 million via subscription rights exercise
  • Eckert Wagniskapital und Frühphasenfinanzierung bought Pentixapharm shares via the exercise of subscription rights.
  • Transaction disclosed as a closely associated person to supervisory board member Dr. Andreas Eckert.
  • Price set at EUR 1.85; total purchase volume EUR 7.34 million.
  • Deal date July 30, 2026; executed off-venue.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pentixapharm Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: dd_106652_de) on August 17, 2026, and is solely responsible for the information contained therein.